← brief for 2026-08-21 · Slowing decline

Lactulose vs Lactobacillus acidophilus for patients with chronic kidney disease: A randomized controlled trial.

Article B Peer reviewed Small trial

Key takeaways

In patients with chronic kidney disease (CKD), co-administration of lactulose and Lactobacillus acidophilus reduced intestinal toxin accumulation. This was a small trial with 24 patients followed for 8 weeks. The combination therapy slowed kidney function decline better than lactulose alone.

Who did this work

Mubarak AS · Elshazly A · Mokhtar A · Gadelkareem RA · Azoz NM

Source

Article · PubMed, CKD progression and prevention · 2026 Sep 25
https://pubmed.ncbi.nlm.nih.gov/42626286/